FDA Approves groundbreaking drug for schizophrenia treatment
On Thursday, the U.S. Food and Drug Administration (FDA) approved the drug Cobenfy which targets schizophrenia in a new way.
Cobenfy: The First New Schizophrenia Drug in Decades
The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...
Experts hail new schizophrenia drug Cobenfy as a game-changer, the ‘first of its kind’
Cobenfy is the first schizophrenia drug in decades to treat the mental health condition in a new way, with potentially fewer ...
Valley News Live6h
FDA approves new drug for schizophrenia, described as a potential ‘game changer’
FARGO, N.D. (Valley News Live) - Changes are coming to the way schizophrenia is treated. The US Food and Drug Administration ...
MyChesCo on MSN32m
FDA Approves Cobenfy, Pioneering New Approach to Schizophrenia Treatment
The U.S. Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) for the treatment of ...
ETX Daily Up on MSN16h
New drug for schizophrenics has experts excited
New drug for schizophrenics has experts excited Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in decades. "This drug takes ...
Medscape12h
Clozapine and Respiratory Infection Risk: What to Know
Recent research is painting a clearer picture of the link between the use of clozapine for schizophrenia and respiratory ...
FDA approves new drug for treatment of schizophrenia
The U.S. Food and Drug Administration approved a new drug for the treatment of schizophrenia in adults. Dr. Darien Sutton explains.
BMJ16h
Schizophrenia: US approves first new treatment in decades
The US Food and Drug Administration (FDA) has approved xanomeline and trospium chloride capsules (Cobenfy) for the treatment of schizophrenia in adults. The drug is the first antipsychotic treatment ...
Program: How a new drug could change lives for people with schizophrenia
Schizophrenia was first identified almost 140 years ago, affects around 24 million people worldwide but remains one of the ...
mindsitenews14h
Will a New Schizophrenia Drug Improve Peoples’ Lives?
The FDA approved a new drug for schizophrenia. Discrimination is stressing Chinese Americans and damaging their mental health.
Synthetic THC may decrease agitation in Alzheimer's patients
A synthetic form of the active ingredient in cannabis helps reduce agitation in people with Alzheimer's, new research shows.